Table 1.
A Detailed Overview of the Studies and Models Described, along with the fpVCT Protocol Used for Each Model.
| Animal Model | Strain | Number of Animals | Intravenous Contrast Medium | Anesthesia | Scanning Parameters | Reconstruction Kernel |
| Mouse anatomy (no pathology) | Nude mice | 5 | Scanned both with no contrast agent, and with 0.2 ml of Iomeprol 400 | Inhalative | Soft tissue: 70 kV/200 mA, 8 seconds per rotation, after contrast medium injection | Standard for soft tissue and angiography |
| Bone/lung: 120 kV/40 mA, 8 seconds per rotation, two rotations | Edge defining for the lung and bone protocol | |||||
| LLC | C57BL/6N | 5 | None | Intraperitoneal | 120 kV/40 mA, 8 seconds per rotation, one rotation | Edge defining |
| Lung fibrosis | C57BL/6N | 5 | None | Intraperitoneal | 120 kV/40 mA, 8 seconds per rotation, one rotation | Edge defining |
| Perfusion (no pathology) | Sprague-Dawley | 4 | 1 ml of Iopromid 300 | Intraperitoneal | 70 kVp/100 mA, 2 seconds per rotation, a total of 16 rotations | Standard |